Transdermal Skin Patches Market: By Product ( Reservoir, Drug in Adhesive, Multilaminate, Matrix), By Application ( Hormone Replacement, Pain Relief, Motion Sickness, Nicotine Cessation, Neurological Disorder, Cardiovascular Disorders), By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Others) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Transdermal Skin Patches Market was valued at USD 7,244.34 million in 2022 and is expected to grow at USD 9,572.35 million by 2028 recording a significant CAGR of 4.79% from 2023-2029. Transdermal skin patches are the adhesive patches which contain medicaments, placed on the skin and delivers the specific dosage of medication into the blood stream through the skin. Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period. In Febrauary 2015, China National Bluestar (Group) Co, Ltd. has launched Silbone soft silicone adhesive for skin application including transdermal patches.

Transdermal Skin Patches Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.79%

Largest Market

North America

Fastest Growing Market

Europe
Transdermal Skin Patches Market Dynamics

Global transdermal skin patches market is primarily driven by the advantages of transdermal skin patches over the oral administration of the medicaments such as ease of administration, enhanced bioavailability, onset of action and prolonged activity of the drug. In addition, adaptation of the transdermal skin patches for the pain relief and new product launches and R&D expected to boost the transdermal skin patches market over the forecast period. Moreover, transdermal skin patches help in effective administration of the drugs which have the narrow therapeutic range. In addition, elimination of the first pass metabolism effected and ease of use effect the prescription of the transdermal skin patches for the drugs having narrow therapeutic window. However, skin permeability of the range of drugs limits the growth of market. Only handful of drugs are suitable for the transdermal drug delivery. Furthermore, disadvantages such as chances of developing contact dermatitis may hamper the market growth over the forecast period.

Key Features of the Reports

  • The transdermal skin patches market report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Transdermal Skin Patches Market Segmentation

By Product
  • Reservoir
  • Drug in Adhesive
  • Multilaminate
  • Matrix
By Application
  • Hormone Replacement
  • Pain Relief
  • Motion Sickness
  • Nicotine Cessation
  • Neurological Disorder
  • Cardiovascular Disorders
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Frequently Asked Questions

The key segments covered in the Transdermal Skin Patches Market are technology, components, application, and end-users.

The Transdermal Skin Patches Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Transdermal Skin Patches Market key players Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc., 3M Company, Accrux Ltd., Access Pharmaceuticals Inc.

1.Executive Summary
2.Global Transdermal Skin Patches Market Introduction 
2.1.Global Transdermal Skin Patches Market  - Taxonomy
2.2.Global Transdermal Skin Patches Market  - Definitions
2.2.1.Product
2.2.2.Application
2.2.3.Distribution Channel
2.2.4.Region
3.Global Transdermal Skin Patches Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Transdermal Skin Patches Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Transdermal Skin Patches Market  By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Reservoir
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Drug in Adhesive
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Multilaminate
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Matrix
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Transdermal Skin Patches Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hormone Replacement
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Pain Relief
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Motion Sickness
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Nicotine Cessation
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Neurological Disorder
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Cardiovascular Disorders
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7.Global Transdermal Skin Patches Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Transdermal Skin Patches Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Reservoir
9.1.2.Drug in Adhesive
9.1.3.Multilaminate
9.1.4.Matrix
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hormone Replacement
9.2.2.Pain Relief
9.2.3.Motion Sickness
9.2.4.Nicotine Cessation
9.2.5.Neurological Disorder
9.2.6.Cardiovascular Disorders
9.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Others
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Reservoir
10.1.2.Drug in Adhesive
10.1.3.Multilaminate
10.1.4.Matrix
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hormone Replacement
10.2.2.Pain Relief
10.2.3.Motion Sickness
10.2.4.Nicotine Cessation
10.2.5.Neurological Disorder
10.2.6.Cardiovascular Disorders
10.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Others
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Reservoir
11.1.2.Drug in Adhesive
11.1.3.Multilaminate
11.1.4.Matrix
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hormone Replacement
11.2.2.Pain Relief
11.2.3.Motion Sickness
11.2.4.Nicotine Cessation
11.2.5.Neurological Disorder
11.2.6.Cardiovascular Disorders
11.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Others
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Reservoir
12.1.2.Drug in Adhesive
12.1.3.Multilaminate
12.1.4.Matrix
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hormone Replacement
12.2.2.Pain Relief
12.2.3.Motion Sickness
12.2.4.Nicotine Cessation
12.2.5.Neurological Disorder
12.2.6.Cardiovascular Disorders
12.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Others
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Transdermal Skin Patches Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Reservoir
13.1.2.Drug in Adhesive
13.1.3.Multilaminate
13.1.4.Matrix
13.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Hormone Replacement
13.2.2.Pain Relief
13.2.3.Motion Sickness
13.2.4.Nicotine Cessation
13.2.5.Neurological Disorder
13.2.6.Cardiovascular Disorders
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Others
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Teva Pharmaceutical Industries Ltd.
14.2.2.Mylan Pharmaceuticals Inc.
14.2.3.3M Company
14.2.4.Accrux Ltd.
14.2.5.Access Pharmaceuticals Inc.
15. Research Methodology 
16. Appendix and Abbreviations 
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals Inc.
  • 3M Company
  • Accrux Ltd.
  • Access Pharmaceuticals Inc.

Adjacent Markets